Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle.

PubWeight™: 1.46‹?› | Rank: Top 5%

🔗 View Article (PMID 9688857)

Published in Am J Physiol on July 01, 1998

Authors

J G Tidball1, E Lavergne, K S Lau, M J Spencer, J T Stull, M Wehling

Author Affiliations

1: Department of Physiological Science, University of California, Los Angeles, Los Angeles, California 90095, USA.

Articles citing this

Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev (2008) 5.74

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol (2001) 3.41

Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J Appl Physiol (1985) (2008) 2.20

A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol Biol Cell (2000) 1.75

NO as a signalling molecule in the nervous system. Br J Pharmacol (2002) 1.46

Release of hepatocyte growth factor from mechanically stretched skeletal muscle satellite cells and role of pH and nitric oxide. Mol Biol Cell (2002) 1.32

Interactions between neutrophils and macrophages promote macrophage killing of rat muscle cells in vitro. J Physiol (2002) 1.31

Adaptation of mouse skeletal muscle to long-term microgravity in the MDS mission. PLoS One (2012) 1.23

Reactive oxygen species: impact on skeletal muscle. Compr Physiol (2011) 1.14

Real-time measurement of nitric oxide in single mature mouse skeletal muscle fibres during contractions. J Physiol (2007) 1.09

Time course analysis of mechanical ventilation-induced diaphragm contractile muscle dysfunction in the rat. J Physiol (2014) 1.06

Reactive oxygen species and redox-regulation of skeletal muscle adaptations to exercise. Philos Trans R Soc Lond B Biol Sci (2005) 1.06

Impaired vasomodulation is associated with reduced neuronal nitric oxide synthase in skeletal muscle of ovariectomized rats. J Physiol (2003) 1.04

Expression of a muscle-specific, nitric oxide synthase transgene prevents muscle membrane injury and reduces muscle inflammation during modified muscle use in mice. J Physiol (2003) 1.03

The role of neutrophils in injury and repair following muscle stretch. J Anat (2006) 1.02

Age-related loss of nitric oxide synthase in skeletal muscle causes reductions in calpain S-nitrosylation that increase myofibril degradation and sarcopenia. Aging Cell (2012) 0.98

Molecular biomarkers monitoring human skeletal muscle fibres and microvasculature following long-term bed rest with and without countermeasures. J Anat (2008) 0.95

Null mutation of myeloperoxidase in mice prevents mechanical activation of neutrophil lysis of muscle cell membranes in vitro and in vivo. J Physiol (2005) 0.93

Exercise training modulates the nitric oxide synthase profile in skeletal muscle from old rats. J Gerontol A Biol Sci Med Sci (2009) 0.90

Protective action of a hexane crude extract of Pterodon emarginatus fruits against oxidative and nitrosative stress induced by acute exercise in rats. BMC Complement Altern Med (2005) 0.89

Nitric oxide synthase inhibitors reduce sarcomere addition in rat skeletal muscle. J Physiol (1999) 0.86

Various jobs of proteolytic enzymes in skeletal muscle during unloading: facts and speculations. J Biomed Biotechnol (2012) 0.85

The role of nitric oxide in the mechanical repression of RANKL in bone stromal cells. Bone (2008) 0.85

Nitric oxide synthase deficiency and the pathophysiology of muscular dystrophy. J Physiol (2014) 0.84

NO skeletal muscle derived relaxing factor in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A (1998) 0.82

Ca2+ Binding/Permeation via Calcium Channel, CaV1.1, Regulates the Intracellular Distribution of the Fatty Acid Transport Protein, CD36, and Fatty Acid Metabolism. J Biol Chem (2015) 0.81

Electrical stimulation of embryonic neurons for 1 hour improves axon regeneration and the number of reinnervated muscles that function. J Neuropathol Exp Neurol (2013) 0.79

Whole-body vibration and blood flow and muscle oxygenation: a meta-analysis. J Athl Train (2015) 0.79

Nitrosative stress in human skeletal muscle attenuated by exercise countermeasure after chronic disuse. Redox Biol (2013) 0.78

Nitric oxide availability is increased in contracting skeletal muscle from aged mice, but does not differentially decrease muscle superoxide. Free Radic Biol Med (2014) 0.77

Immediate force loss after eccentric contractions is increased with L-NAME administration, a nitric oxide synthase inhibitor. Muscle Nerve (2013) 0.77

No-dependent signaling pathways in unloaded skeletal muscle. Front Physiol (2015) 0.76

nNOS regulation of skeletal muscle fatigue and exercise performance. Biophys Rev (2011) 0.75

Effects of passive static stretching on blood glucose levels in patients with type 2 diabetes mellitus. J Phys Ther Sci (2015) 0.75

Effects of Static Stretching on Squat Performance in Division I Female Athletes. Int J Exerc Sci (2016) 0.75

Human muscle signaling responses to 3-day head-out dry immersion. J Musculoskelet Neuronal Interact (2015) 0.75

Cardiovascular Responses to Skeletal Muscle Stretching: "Stretching" the Truth or a New Exercise Paradigm for Cardiovascular Medicine? Sports Med (2017) 0.75

Articles by these authors

Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab (1965) 14.95

The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol (1985) 4.80

Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem (2000) 3.89

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol (2001) 3.41

Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A (1998) 3.00

Multiple actions of steroid hormones--a focus on rapid, nongenomic effects. Pharmacol Rev (2000) 2.94

Myosin light chain phosphorylation in vertebrate striated muscle: regulation and function. Am J Physiol (1993) 2.81

Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A (2000) 2.49

Epidemic measles in young adults. Clinical, epidemiologic, and serologic studies. Ann Intern Med (1979) 2.29

Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci U S A (1996) 2.06

Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol (1999) 2.01

Attenuation of heart-rate variability in postmenopausal women on progestin-containing hormone replacement therapy. Lancet (1999) 1.98

Regulation of smooth muscle contractile elements by second messengers. Annu Rev Physiol (1989) 1.98

The effect of myosin phosphorylation on the contractile properties of skinned rabbit skeletal muscle fibers. J Biol Chem (1985) 1.95

A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited. Arthritis Rheum (1998) 1.90

Alteration of cross-bridge kinetics by myosin light chain phosphorylation in rabbit skeletal muscle: implications for regulation of actin-myosin interaction. Proc Natl Acad Sci U S A (1990) 1.87

Myosin light chain phosphorylation affects the structure of rabbit skeletal muscle thick filaments. Biophys J (1996) 1.75

Measurement of cyclic 3',5'-denosine monophosphate by the activation of skeletal muscle protein kinase. J Biol Chem (1971) 1.72

Phosphorylation of the inhibitor component of troponin by phosphorylase kinase. J Biol Chem (1972) 1.71

Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes. Eur J Biochem (1996) 1.70

Charge replacement near the phosphorylatable serine of the myosin regulatory light chain mimics aspects of phosphorylation. Proc Natl Acad Sci U S A (1994) 1.67

Myosin light chain kinases. J Muscle Res Cell Motil (1997) 1.67

Phosphorylation of myosin in permeabilized mammalian cardiac and skeletal muscle cells. Am J Physiol (1986) 1.66

Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. Int Angiol (2012) 1.60

Adenovirus infection in the immunocompromised patient. Am J Med (1980) 1.59

Molecular characterization of a mammalian smooth muscle myosin light chain kinase. J Biol Chem (1991) 1.59

Smoking and tuberculosis in Hong Kong. Int J Tuberc Lung Dis (2003) 1.54

Inactivation of purified ox kidney branched-chain 2-oxoacid dehydrogenase complex by phosphorylation. FEBS Lett (1981) 1.54

nNOS and eNOS modulate cGMP formation and vascular response in contracting fast-twitch skeletal muscle. Physiol Genomics (2000) 1.54

Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett (2000) 1.50

Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation. J Biol Chem (2000) 1.50

HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. N Engl J Med (1976) 1.49

The amino acid sequences of the phosphorylated sites in troponin-I from rabbit skeletal muscle. FEBS Lett (1974) 1.49

Regulation of the branched chain 2-oxoacid dehydrogenase kinase reaction. FEBS Lett (1982) 1.48

Cloning and tissue expression of two putative steroid membrane receptors. Biol Chem (1998) 1.48

Activation of skeletal muscle myosin light chain kinase by calcium(2+) and calmodulin. Biochemistry (1980) 1.43

Structures of calmodulin and a functional myosin light chain kinase in the activated complex: a neutron scattering study. Biochemistry (1997) 1.41

Phosphorylation of cardiac troponin by cyclic adenosine 3':5'-monophosphate-dependent protein kinase. J Biol Chem (1977) 1.41

Ca(2+)-dependent phosphorylation of myosin light chain kinase decreases the Ca2+ sensitivity of light chain phosphorylation within smooth muscle cells. J Biol Chem (1994) 1.40

Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem Biophys Res Commun (1996) 1.40

Dientamoeba fragilis. An intestinal pathogen in children? Am J Dis Child (1979) 1.39

Activation of four enzymes by two series of calmodulin mutants with point mutations in individual Ca2+ binding sites. J Biol Chem (1993) 1.35

Structure and regulation of calcium/calmodulin-dependent protein kinases. Chem Rev (2001) 1.35

Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci (1995) 1.35

Adsorption of I-131-triiodothyronine (T3) from serum by charcoal as an in vitro test of thyroid function. J Lab Clin Med (1965) 1.31

Myosin light chain phosphorylation in fast and slow skeletal muscles in situ. Am J Physiol (1984) 1.31

Different phosphorylated forms of myosin in contracting tracheal smooth muscle. J Biol Chem (1986) 1.30

GTP gamma S-dependent regulation of smooth muscle contractile elements. Am J Physiol (1992) 1.29

Localization and activity of myosin light chain kinase isoforms during the cell cycle. J Cell Biol (2000) 1.29

Measurement of chemical phosphate in proteins. Methods Enzymol (1983) 1.29

Activation of smooth muscle contraction: relation between myosin phosphorylation and stiffness. Science (1986) 1.27

Sites phosphorylated in myosin light chain in contracting smooth muscle. J Biol Chem (1988) 1.27

Myosin light chain phosphorylation and phosphorylase A activity in rat extensor digitorum longus muscle. Biochem Biophys Res Commun (1979) 1.27

[Prevention of adverse drug reactions in older patients]. Z Gerontol Geriatr (2007) 1.27

Vasculas complications in nephrotic syndrome: relationship to steroid therapy and accelerated thromboplastin generation. Br Med J (1970) 1.26

Nitric oxide contributes to vascular smooth muscle relaxation in contracting fast-twitch muscles. Physiol Genomics (2001) 1.25

Phosphorylation of myosin in perfused rabbit and rat hearts. Am J Physiol (1980) 1.25

Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations. Am J Hum Genet (1993) 1.25

Inactivation of rat liver and kidney branched chain 2-oxoacid dehydrogenase complex by adenosine triphosphate. FEBS Lett (1981) 1.25

Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide. FEBS Lett (1998) 1.23

Measles revaccination. Persistence and degree of antibody titer by type of immune response. Am J Dis Child (1978) 1.22

Phosphorylation of myosin light chain kinase by the multifunctional calmodulin-dependent protein kinase II in smooth muscle cells. J Biol Chem (1992) 1.20

Molecular phenotypes in cultured maple syrup urine disease cells. Complete E1 alpha cDNA sequence and mRNA and subunit contents of the human branched chain alpha-keto acid dehydrogenase complex. J Biol Chem (1989) 1.20

The UCLA-University of Utah epidemiologic survey of autism: prenatal, perinatal, and postnatal factors. Pediatrics (1990) 1.19

Myosin light chain phosphorylation-dephosphorylation in mammalian skeletal muscle. Am J Physiol (1982) 1.18

Frequency-dependent myosin light chain phosphorylation in isolated myocardium. J Mol Cell Cardiol (1986) 1.17

Myosin phosphorylation, force, and maximal shortening velocity in neurally stimulated tracheal smooth muscle. Am J Physiol (1985) 1.16

Activation of phosphorylated branched chain 2-oxoacid dehydrogenase complex. FEBS Lett (1982) 1.15

Effects of pH, ionic strength, and temperature on activation by calmodulin an catalytic activity of myosin light chain kinase. Biochemistry (1982) 1.15

The binding of drugs to different polar lipids in vitro. Biochem Pharmacol (1979) 1.14

Identification of a novel actin binding motif in smooth muscle myosin light chain kinase. J Biol Chem (1999) 1.13

Contractile elements and myosin light chain phosphorylation in myometrial tissue from nonpregnant and pregnant women. J Clin Invest (1993) 1.12

Structural and functional responses of mammalian thick filaments to alterations in myosin regulatory light chains. J Struct Biol (1998) 1.12

Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors. Am J Pathol (2000) 1.11

Coated charcoal assay of unsaturated iron-binding capacity. J Lab Clin Med (1966) 1.11

Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J Clin Invest (1994) 1.11

Rapid, nongenomic steroid actions: A new age? Front Neuroendocrinol (2000) 1.09

Classic and non-classic progesterone receptors are both expressed in human spermatozoa. Horm Metab Res (2005) 1.08

Substrate specificity of myosin light chain kinases. J Biol Chem (1992) 1.07

Re-epithelialization of normal human excisional wounds is associated with a switch from alpha v beta 5 to alpha v beta 6 integrins. Br J Dermatol (1996) 1.07

Properties of filament-bound myosin light chain kinase. J Biol Chem (1999) 1.07

Phosphorylation of smooth muscle myosin heavy and light chains. Effects of phorbol dibutyrate and agonists. J Biol Chem (1989) 1.07

Pentastomiasis: a common finding at autopsy among Malaysian aborigines. Am J Trop Med Hyg (1969) 1.07

Expression and characterization of branched-chain alpha-ketoacid dehydrogenase kinase from the rat. Is it a histidine-protein kinase? J Biol Chem (1995) 1.07

Specific progesterone binding to a membrane protein and related nongenomic effects on Ca2+-fluxes in sperm. Endocrinology (1999) 1.07

Domain characterization of rabbit skeletal muscle myosin light chain kinase. J Biol Chem (1990) 1.06

Calpains and muscular dystrophies. Int J Biochem Cell Biol (2000) 1.06

Isolation and sequencing of a cDNA encoding the decarboxylase (E1)alpha precursor of bovine branched-chain alpha-keto acid dehydrogenase complex. Expression of E1 alpha mRNA and subunit in maple-syrup-urine-disease and 3T3-L1 cells. J Biol Chem (1988) 1.06

Calcium dependence of myosin light chain phosphorylation in smooth muscle cells. J Biol Chem (1988) 1.06

Regulation of phosphorylase activation in skeletal muscle in vivo. J Biol Chem (1971) 1.05

Phosphorylation of skeletal muscle contractile proteins in vivo. Biochem Biophys Res Commun (1977) 1.03

Binding of myosin light chain kinase to cellular actin-myosin filaments. J Biol Chem (1997) 1.03

A molecular mechanism for autoinhibition of myosin light chain kinases. J Biol Chem (1993) 1.03

Phosphorylation of contractile proteins in relation to muscle function. Adv Cyclic Nucleotide Res (1980) 1.02

Changes in interfilament spacing mimic the effects of myosin regulatory light chain phosphorylation in rabbit psoas fibers. J Struct Biol (1998) 1.02